Tenderwize
Wróć do wyszukiwania

Open House Original Discount Contracts 2025-17 - Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09)

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 29, 2027 · 308 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-17 - Beclometason, Formoterol, Glycopyrronium (Wirkstoffkombination) ATC: R03AL09

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

30 / 100

Czynniki ryzyka

No estimated contract value provided; potential revenue cannot be assessed.

Contract terminates automatically upon patent expiry or loss of market exclusivity, which could shorten contract durati...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Supply of pharmaceutical products containing active ingredient combination Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09)
  • Nationwide delivery in Germany
Pokaż pełne podsumowanie

Open House procedure (non-procurement) by Techniker Krankenkasse and associated health insurers for discount contracts (Rabattverträge) for the active ingredient combination Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09). The contract is a supply of pharmaceutical products. No estimated value provided. Contract duration max 24 months from 01.07.2025 to 30.06.2027. Participation possible anytime during the contract period. Submission by email (with qualified electronic signature) or post. No exclusivity.

Ryzyka

No estimated contract value provided; potential revenue cannot be assessed.

Contract terminates automatically upon patent expiry or loss of market exclusivity, which could shorten contract durati...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as per §4 Abs. 18 AMG
  • Must hold a valid marketing authorization for the specific drug combination or be entitled to market it

Eligibility

  • Must submit a self-declaration (Anlage 4) confirming eligibility and reliability

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria specified; all qualified participants are accepted.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open House Original Discount Contracts 2025-17 - Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09)

Discount contracts for the active ingredient combination Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09) nationwide in Germany.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Jun 2025 - Jun 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria specified; all qualified participants are accepted.

Termin

Deadline Jun 29, 2027

Szczegóły zamówienia

Data publikacji
22 May 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
332579-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3